(Q34984796)

5 August 2017

1 reference

title

Staging and reporting of urothelial carcinoma of the urinary bladder (English)

1 reference

5 August 2017

2

Rodolfo Montironi

1 reference

5 August 2017

1

Liang Cheng

1 reference

PubMed ID

19494855

5 August 2017

Antonio Lopez-Beltran

series ordinal

4

object named as

Antonio Lopez-Beltran

1 reference

5 August 2017

Darrell D Davidson

3

1 reference

5 August 2017

1 June 2009

1 reference

5 August 2017

1 reference

5 August 2017

22 Suppl 2

1 reference

5 August 2017

S70-95

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.1

5 August 2017

0 references

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Histologic grading of noninvasive papillary urothelial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Holmium laser enucleation of the prostate: a size-independent new "gold standard".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Staging invasive bladder tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Simple cystectomy in the management of bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Carcinoma of the bladder: Treatment by radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Carcinoma of the Urinary Bladder: Clinical staging and histologic grading in relation to survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

A clinicopathologic evaluation of partial cystectomy for carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Impact of the level of muscle invasion in organ-confined bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Microscopic and gross extravesical extension in pathological staging of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Urothelial carcinoma of the prostate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Prospective evaluation of the prognostic relevance of molecular staging for urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Molecular lymph node staging in bladder urothelial carcinoma: impact on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Diagnosis and grading of bladder cancer and associated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

ASCP survey on anatomic pathology examination of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Bladder cancer: epidemiology, staging and grading, and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

The pathology of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Bladder. Risk and prognostic factors--a pathologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Molecular evidence supporting field effect in urothelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

Bladder cancer: state-of-the-art care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Cystectomy for bladder cancer: a contemporary series

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

It is time to abandon the "superficial" in bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Eliminate the term "superficial" bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Cancer specific outcomes in patients with pT0 disease following radical cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Outcome of radical cystectomy for bladder cancer according to the disease type at presentation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Value of immunohistochemistry in staging T1 urothelial bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Management of stage T1 tumors of the bladder: International Consensus Panel.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Progression of T1 bladder tumors: better staging or better biology?: reply

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Predicting cancer progression in patients with stage T1 bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Contemporary management of stage T1 transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Muscularis mucosa differentiates two populations with different prognosis in stage T1 bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

The influence of the level of lamina propria invasion and the prevalence of p53 nuclear accumulation on survival in stage T1 transitional cell bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Invasive carcinomas of the urinary bladder. Evaluation of tunica muscularis mucosae involvement

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Muscularis mucosa of urinary bladder. Importance for staging and treatment

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

The muscularis mucosae of the human urinary bladder. Implications for tumor staging on biopsies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Predicting extravesical extension of bladder carcinoma: a novel method based on micrometer measurement of the depth of invasion in transurethral resection specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Carcinoma of the bladder: influence of depth of infiltration on the 5-year results following complete extirpation of the primary growth

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Staging error in the bladder tumor: the correlation between stage of TUR and cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

A proposed simplified staging system of invasive bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Current Perspectives in the Management of High-Grade Invasive Bladder Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Bladder carcinoma: results with preoperative radiation therapy and radical cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Risk of local urethral recurrence after radical cystectomy for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

The curability if invasive bladder cancer treated by radical cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Total Cystectomy for Bladder Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Pathology an prognosis folowing total cystectomy for carcinoma of bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Radical Cystectomy for Carcinoma of the Bladder: 16 Years of Experience

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Long-term patient survival after cystectomy for regional metastatic transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Stage B () transitional cell carcinoma of bladder highly curable by radical cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Radical Cystectomy for Bladder Cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Radical Cystectomy without Radiation Therapy for Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Pathological staging of muscle invasive bladder cancer. Is substaging of pT2 tumors really necessary?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Editorial: Comments on the Staging of Invasive Bladder Cancer Two B’s or Not Two B’s: That is the Question (Apologies to Shakespeare, Hamlet. Act iii, Sc. I, 1. 56)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Intravesical adipose tissue: a quantitative study of its presence and location with implications for therapy and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Outcome in patients with seminal vesicle invasion after radical cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Superiority of ratio based lymph node staging for bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Can immunohistochemistry enhance the detection of micrometastases in pelvic lymph nodes from patients with high-grade urothelial carcinoma of the bladder?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Pathologic evaluation of radical cystectomy specimens: a cooperative group report

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Patterns of invasion and histological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Superficial bladder cancer: progression and recurrence

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Mapping of the urinary bladder: Its impact on the concepts of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Clonal origin of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Muscle-invasive bladder cancer: predictive factors and prognostic difference between primary and progressive tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

The prognostic significance of vascular invasion in stage T1 bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.1

7 January 2021

Identifiers

DOI

10.1038/MODPATHOL.2009.1

1 reference

PubMed ID

19494855

Dimensions Publication ID

5 August 2017

0 references

1 reference

PubMed ID

19494855